All Stories

UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/3 trial.

Mar 4, 2025 - 15:37
 0
UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial
Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/3 trial.
Read More

Tags:

Previous Article

Gen Z used BNPL more than credit cards over holidays, survey shows

Next Article

Ella’s Kitchen announces two NPD launches

Related Posts

Pliant pauses phase 2 lung fibrosis trial on advice of safety committee

Pliant pauses phase 2 lung fibrosis trial on advice of ...

Feb 10, 2025  0

Wearable defibrillator maker Kestra Medical plots $150M IPO

Wearable defibrillator maker Kestra Medical plots $150M...

Feb 26, 2025  0

Kura and Kyowa hail phase 2 win for leukemia drug soon heading to FDA, but hold back data

Kura and Kyowa hail phase 2 win for leukemia drug soon ...

Feb 9, 2025  0